Paper19592011
Dexamethasone alters the hepatic inflammatory cellular profile without changes in matrix degradation during liver repair following biliary decompression.
Muratore CS and 3 others. J Surg Res, 2009. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Dexamethasone alters the hepatic inflammatory cellular profile without changes in matrix degradation during liver repair following biliary decompression. Papers, record 19592011. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19592011
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dexamethasone alters the hepatic inflammatory cellular profile without changes in matrix degradation during liver repair following biliary decompression.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents | Major topic |
| Biliary Atresia | Major topic |
| Dexamethasone | Major topic |
| Kupffer Cells | Major topic |
| Liver | Major topic |
| Animals | |
| Bile Ducts | |
| Cholestasis | |
| Collagen | |
| Cytokines | |
| Decompression, Surgical | |
| Disease Models, Animal | |
| Extracellular Matrix Proteins | |
| Liver Cirrhosis | |
| Macrophages | |
| Male | |
| Neutrophils | |
| Rats |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 DK046831 | NIDDK NIH HHS | United States | R01DK046831 | PubMed and NIH |
| R01 DK46831 | NIDDK NIH HHS | United States | R01DK046831 | PubMed and NIH |
Source NIH RePORTER
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7595823 | Degeneration of intrahepatic bile duct with lymphocyte infiltration into biliary epithelial cells in biliary atresia. | J Pediatr Surg | 1995 | https://conductscience.org/library/papers/7595823 | PubMed |
| 2 | 8632264 | The inflammatory response in pediatric biliary disease: macrophage phenotype and distribution. | J Pediatr Surg | 1996 | https://conductscience.org/library/papers/8632264 | PubMed |
| 3 | 10207698 | The influence of cholangitis on the prognosis of extrahepatic biliary atresia. | Eur J Pediatr Surg | 1999 | https://conductscience.org/library/papers/10207698 | PubMed |
| 4 | 18436015 | Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. | Surgery | 2008 | https://conductscience.org/library/papers/18436015 | PubMed |
| 5 | 10792959 | Kupffer cell inactivation delays repair in a rat model of reversible biliary obstruction. | J Surg Res | 2000 | https://conductscience.org/library/papers/10792959 | PubMed |
| 6 | 12632357 | High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. | J Pediatr Surg | 2003 | https://conductscience.org/library/papers/12632357 | PubMed |
| 7 | 11112835 | Biliary atresia. | Semin Pediatr Surg | 2000 | https://conductscience.org/library/papers/11112835 | PubMed |
| 8 | 7821959 | Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. | Immunology | 1994 | https://conductscience.org/library/papers/7821959 | PubMed |
| 9 | 2314093 | A model of reversible obstructive jaundice in the rat. | J Surg Res | 1990 | https://conductscience.org/library/papers/2314093 | PubMed |
| 10 | 12852435 | The pharmacokinetic and biological activity profile of dexamethasone targeted to sinusoidal endothelial and Kupffer cells. | J Drug Target | 2003 | https://conductscience.org/library/papers/12852435 | PubMed |
| 11 | 17935230 | Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. | Hepatology | 2007 | https://conductscience.org/library/papers/17935230 | PubMed |
| 12 | 17706489 | Kasai portoenterostomy: 12-year experience with a novel adjuvant therapy regimen. | J Pediatr Surg | 2007 | https://conductscience.org/library/papers/17706489 | PubMed |
| 13 | 7519822 | Increased expression of intercellular adhesion molecules in biliary atresia. | Am J Pathol | 1994 | https://conductscience.org/library/papers/7519822 | PubMed |
| 14 | 10547847 | Primer3 on the WWW for general users and for biologist programmers. | Methods Mol Biol | 2000 | https://conductscience.org/library/papers/10547847 | PubMed |
| 15 | 9339941 | A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. | Ann Surg | 1997 | https://conductscience.org/library/papers/9339941 | PubMed |
| 16 | 11241420 | CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis. | J Pathol | 2001 | https://conductscience.org/library/papers/11241420 | PubMed |
| 17 | 11150442 | Immunosuppression as adjuvant therapy for biliary atresia. | J Pediatr Surg | 2001 | https://conductscience.org/library/papers/11150442 | PubMed |
| 18 | 1375180 | Intrahepatic bile duct loss in biliary atresia despite portoenterostomy: a consequence of ongoing obstruction? | Gastroenterology | 1992 | https://conductscience.org/library/papers/1375180 | PubMed |
| 19 | 9247243 | The improved outlook for biliary atresia with corticosteroid therapy. | J Pediatr Surg | 1997 | https://conductscience.org/library/papers/9247243 | PubMed |
| 20 | 16410116 | Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. | J Pediatr Surg | 2006 | https://conductscience.org/library/papers/16410116 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40445412 | Development and validation of a prediction model for cholangitis after percutaneous transhepatic cholangioscopic lithotripsy. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40445412 | PubMed |
| 38912031 | Delphi Method Analysis and Consensus of Prevalent Distinctive Practices for Biliary Atresia Management after Kasai Portoenterostomy. | J Indian Assoc Pediatr Surg | 2024 | https://conductscience.org/library/papers/38912031 | PubMed |
| 24838399 | Hepatocytes buried in the cirrhotic livers of patients with biliary atresia proliferate and function in the livers of urokinase-type plasminogen activator-NOG mice. | Liver Transpl | 2014 | https://conductscience.org/library/papers/24838399 | PubMed |
| 21468628 | Dexamethasone pretreatment attenuates lung and kidney injury in cholestatic rats induced by hepatic ischemia/reperfusion. | Inflammation | 2012 | https://conductscience.org/library/papers/21468628 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19592011
GET https://conductscience.org/api/papers/v1/19592011/references?page=2